. 2016 Mar 1;7(16):21658–21675. doi: 10.18632/oncotarget.7808

Table 1. EC₅₀^a (μM) derived from TO displacement (FID) by selected AQ and AN derivatives from G4 folded KIT sequences.

	AQ1	AQ5	AQ3	AQ7	AN6
KIT1	0.32 ± 0.05	0.27 ± 0.02	0.50 ± 0.04	0.24 ± 0.04	4.11 ± 0.70
KIT2	0.35 ± 0.05	0.41 ± 0.03	0.62 ± 0.05	0.25 ± 0.02	3.63 ± 1.00

ligand concentration that displaces 50% of TO from tested DNA sequences.

Table 1. EC50a (μM) derived from TO displacement (FID) by selected AQ and AN derivatives from G4 folded KIT sequences.